Related Experiment Video
Updated: Oct 30, 2025

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
High-sensitivity troponins in dialysis patients: variation and prognostic value
Sunna Snaedal1,2, Peter Bárány1, Sigrún H Lund3
1Department of Clinical Science, Intervention and Technology, Division of Renal Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Insights
Elevated cardiac troponins (cTns) are common in dialysis patients. Persistently high troponin T levels significantly increase mortality risk, highlighting the need for serial monitoring in this population.
Area of Science:
- Nephrology
- Cardiology
- Biomarker Research
Background:
- Dialysis patients face high cardiovascular mortality.
- Elevated cardiac troponins (cTns) are prevalent, even without acute cardiac ischemia.
- Understanding cTn variability and prognostic value is crucial.
Purpose of the Study:
- To assess the variation and prognostic significance of high-sensitivity cardiac troponin I (cTnI) and troponin T (cTnT) in prevalent dialysis patients.
- To evaluate the diagnostic utility of serial cTn measurements in this cohort.
Main Methods:
- Serum cTnI and cTnT measured every 4 months in 198 hemodialysis (HD) and 78 peritoneal dialysis (PD) patients.
- Variability assessed using Reference Change Values (RCVs).
- Survival analyses conducted using competing-risk regression models over a 50-month follow-up.
Main Results:
- Similar troponin levels observed between HD and PD patients.
- A high percentage of patients had troponin levels above myocardial infarction decision levels (42% for cTnI, 98% for cTnT).
- Elevated troponin T, but not cTnI, predicted mortality after adjusting for confounders.
Conclusions:
- Many dialysis patients without active cardiac events exhibit elevated high-sensitivity cTns.
- Persistently high troponin T levels were associated with doubled mortality risk.
- Large intraindividual cTn variation suggests serial measurements and RCVs can enhance diagnostic utility, though further research is needed.
Background:
Dialysis patients have a high prevalence of cardiovascular mortality but also elevated cardiac troponins (cTns) even without signs of cardiac ischaemia. The study aims to assess variation and prognostic value of high-sensitivity cTnI and cTnT in prevalent dialysis patients.
Methods:
In 198 prevalent haemodialysis (HD) and 78 peritoneal dialysis (PD) patients, 4-monthly serum troponin I and T measurements were obtained. Reference change values (RCVs) were used for variability assessment and competing-risk regression models for survival analyses; maximal follow-up was 50 months.
Results:
HD and PD patients had similar troponin levels [median (interquartile range) troponin I: 25 ng/L (14-43) versus 21 ng/L (11-37), troponin T: 70 ng/L (44-129) versus 67 ng/L (43-123)]. Of troponin I and T levels, 42% versus 98% were above the decision level of myocardial infarction. RCVs were +68/-41% (troponin I) and +29/-23% (troponin T). Increased variability of troponins related to higher age, male sex, protein-energy wasting and congestive heart failure, but not ischaemic heart disease or dialysis form. Elevated troponin T, but not troponin I, predicted death after adjusting for confounders.
Conclusions:
A large proportion of prevalent dialysis patients without current established or ongoing cardiac events have elevated levels of high-sensitivity cTns. Mortality risk was doubled in patients with persistently high troponin T levels. The large intraindividual variation of cTns suggests that serial measurements and reference change levels may be used to improve diagnostic utility. However, evidence-based recommendations require more data from large studies of dialysis patients with cardiac events.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Coronary Syndrome III: Diagnostic Studies
Chronic Kidney Disease III: Interprofessional Care
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Serum Studies: Renal Function Tests

